Purdue Pharma has sought to delay a trial that is set to begin May 28 in Oklahoma, citing a “belated tidal wave of documents,” but the move comes amid reports that the opioid manufacturer could soon file for Chapter 11 bankruptcy.

In a case brought by the Oklahoma attorney general, the trial would be the first time a jury would decide whether Purdue was responsible for the opioid addiction crisis. Last week, Purdue filed a motion for continuance based on a massive data dump handed over by the attorney general's office. On Friday, Attorney General Mike Hunter countered that Purdue's motion was a ruse that, along with a potential bankruptcy filing, were all part of a “desperate” attempt to avoid trial.

“There is no way—no way—any of these defendants can face a jury,” wrote Hunter and the state's Oklahoma City attorneys, former federal judge Michael Burrage of Whitten Burrage, and Bradley Beckworth, co-head of Nix Patterson's complex litigation group. “Defendants know they can't hide anymore. Now they're trying to run.”